Core Viewpoint - The document outlines the management system for the trading of shares by directors and senior management of Changjiang Pharmaceutical Holdings Co., Ltd, emphasizing compliance with relevant laws and regulations to prevent insider trading and ensure transparency in share transactions [1][2][3]. Group 1: General Principles - The management system is established to strengthen the oversight of shareholding and trading activities by directors and senior management, in accordance with the Company Law, Securities Law, and relevant regulations [1]. - The system applies to all shares held and traded by directors, senior management, and specified related parties [1]. - Directors and senior management must be aware of prohibitions against insider trading and market manipulation before engaging in share transactions [1]. Group 2: Reporting and Disclosure - Directors and senior management must notify the board secretary in writing of their trading plans, who will verify the status of information disclosure and significant events [2]. - The company is responsible for ensuring that the data submitted to the Shenzhen Stock Exchange and the China Securities Depository and Clearing Corporation is accurate and timely [3]. - Any changes in shareholding must be reported to the board within two trading days and disclosed on the stock exchange [7]. Group 3: Transfer Restrictions - Directors and senior management can only transfer up to 25% of their total shares held annually, with certain exceptions [4]. - Shares held by directors and senior management are subject to lock-up periods, including one year post-listing and six months after leaving the company [6]. - The company must apply for the registration of shares with transfer restrictions when certain conditions are met, such as during equity incentive plans [2]. Group 4: Penalties and Compliance - Any profits gained from prohibited trading activities must be returned to the company, and the board is responsible for recovering these profits [5]. - Violations of trading regulations may lead to disciplinary actions against responsible individuals [8]. - The board has the authority to interpret the management system and make necessary amendments in accordance with legal requirements [8].
*ST长药: 董事、高级管理人员持有和买卖本公司股票管理制度(2025年6月)
Zheng Quan Zhi Xing·2025-06-26 16:44